Premarin® Conjugated Estrogen Vaginal Cream 14 g
PRIMO – Methenolone Enanthate Injection
Primo 100mg Injection USP – Methenolone Enanthate
Raloxifene Hydrochloride Tablets IP 60 mg – Complete Product Information
Brand Name
Raloxis (or as per actual brand on pack)
Generic Name
Raloxifene Hydrochloride
Dosage Form
Tablet
Strength / Composition
Each tablet contains:
-
Raloxifene Hydrochloride IP 60 mg
Excipients: q.s.
Pack Size
10 × 10 Tablets
(1 Box contains 100 Tablets)
Route of Administration
Oral
Category
Selective Estrogen Receptor Modulator (SERM)
Anti-osteoporotic Agent
Rebomed-DSR Capsules (Rabeprazole Sodium EC & Domperidone SR) – 1 Box (100 Capsules)
Brand Name: Rebomed-DSR
Generic Name: Rabeprazole Sodium (EC) + Domperidone (SR)
Dosage Form: Capsule
Strength / Composition:
-
Rabeprazole Sodium IP – 20 mg (Enteric Coated)
-
Domperidone IP – 30 mg (Sustained Release)
Pack Size: 1 Box (10 × 10 Capsules = 100 Capsules)
Route of Administration: Oral
Category: Proton Pump Inhibitor + Prokinetic Agent
Retatrutide 12 mg Peptide (Research Use Only) Per Voil
Rybelsus 14 mg ( Semaglutide 14 mg) (Per Box)
Packaging Information
-
Product Name: Rybelsus®
-
Generic Name: Semaglutide Tablets 14 mg
-
Strength: 14 mg per tablet
-
Quantity: 10 tablets per pack
-
Form: Oral tablet (film-coated)
-
Packaging Type:
-
Primary: Blister strip
-
Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)
-
Rybelsus 3 mg (Semaglutide 3 mg) (Per Box)
-
Product Name: Rybelsus®
-
Generic Name: Semaglutide Tablets 3 mg
-
Strength: 3 mg per tablet
-
Quantity: 10 tablets per pack
-
Form: Oral tablet (film-coated)
-
Packaging Type:
-
Primary: Blister strip
-
Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)
-
Rybelsus 7 mg (Semaglutide 7 mg) (Per Box)
Rybelsus® 7 mg is an oral GLP-1 receptor agonist containing semaglutide, designed to help adults with type 2 diabetes manage their blood sugar levels effectively. As an intermediate-strength dose, it is commonly used after initial dose titration and provides significant benefits in glycemic control while also supporting weight loss by reducing appetite and slowing digestion. Rybelsus 7 mg offers a convenient, once-daily, non-injectable option for patients seeking improved metabolic health and body weight regulation as part of a comprehensive diabetes care plan.
Packaging Information
-
Product Name: Rybelsus®
-
Generic Name: Semaglutide Tablets 7 mg
-
Strength: 7 mg per tablet
-
Quantity: 10 tablets per pack
-
Form: Oral tablet (film-coated)
-
Tablet Appearance: Oval, light orange, debossed with tablet strength
-
Packaging Type:
-
Primary: Blister strip
-
Secondary: Printed carton box containing blister(s) and patient information leaflet (PIL)
-
